Mai T. Duong

SWOG S1505: Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine/nab-paclitaxel (Gem/nabP) for resectable pancreatic ductal adenocarcinoma (PDA).

Davendra Sohal, Mai T. Duong, Syed A. Ahmad et al. · Journal of Clinical Oncology · 2020 · 114 citations

Surgical Oncology, Clinical Endpoint, Prognosis +20

Activation of inflammasome by attenuated <i>Salmonella typhimurium</i> in bacteria‐mediated cancer therapy

Thuy Phan, Vu H. Nguyen, Mai T. Duong et al. · Microbiology and Immunology · 2015 · 110 citations · Full text

Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimurium

Wenzhi Tan, Mai T. Duong, Chaohui Zuo et al. · Molecular Therapy · 2021 · 68 citations · Full text

Optimized Doxycycline-Inducible Gene Expression System for Genetic Programming of Tumor-Targeting Bacteria

Dinh-Huy Nguyen, Sung-Hwan You, An-Trang Ngoc Vo et al. · Molecular Imaging and Biology · 2021 · 20 citations · Full text

Randomized phase II trial of olaparib + pembrolizumab versus olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (g<i>BRCA</i>1/2+) mutations: SWOG S2001.

Vincent Chung, Katherine A. Guthrie, Michael J. Pishvaian et al. · Journal of Clinical Oncology · 2021 · 12 citations

Immunology, Immunoediting, Pathology +23